SHE · Healthcare

Lifecome Biochemistry Co Ltd (002868)

Biotechnology

Lifecome Biochemistry Co Ltd (002868) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 002868

P/E ratio

25.00

Lifecome Biochemistry Co Ltd (002868) — FAQ

What is 002868's P/E ratio?

The price-to-earnings (P/E) ratio for Lifecome Biochemistry Co Ltd (002868) is 25.00 (data as of 2026-05-23).

Does Lifecome Biochemistry Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Lifecome Biochemistry Co Ltd (002868). Check the MyAverix Finance app for the latest dividend data.

What sector is Lifecome Biochemistry Co Ltd in?

Lifecome Biochemistry Co Ltd (002868) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 002868 listed on?

002868 is listed on SHE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)